Athersys is a clinical late-stage regenerative medicine company developing MultiStem® (invimestrocel) cell therapy. This investor presentation provides an in-depth look at the its current clinical programs in ischemic stroke, acute…
Read More »Programs
Dr. Sarah Busch gives an overview of the exciting preclinical research being conducted by Athersys and collaborators around the world using MultiStem®. Video Chapters: 0:00 Introduction 2:35 Hemorrhagic Stroke 8:50…
Read More »
When it comes to health, there’s simply no alternative to timely treatment and patient-centered care. Source Alzheimer’s Association YouTube
Read More »
UCSF Department of Medicine offers 19 ACGME-accredited clinical fellowship subspecialty programs. Each year, approximately 370 residents conduct their fellowship training at UCSF’s primary training sites, which include UCSF Medical Center,…
Read More »
UCSF Department of Medicine offers 19 ACGME-accredited clinical fellowship subspecialty programs. Each year, approximately 370 residents conduct their fellowship training at UCSF’s primary training sites, which include UCSF Medical Center,…
Read More »